MID-ATLANTIC BIOTHERAPEUTICS: Our website is evolving following our acquisition of XPose Therapeutics. We are driven to expand our current capabilities and strategic focus on Immunotherapy, Oncology and DNA Damage Repair.
We will be back soon with a whole new online presence.